SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Black Bird Biotech, Inc. – ‘10-Q’ for 3/31/22 – ‘EX-101.CAL’

On:  Monday, 5/23/22, at 4:13pm ET   ·   For:  3/31/22   ·   Accession #:  1477932-22-3840   ·   File #:  0-52828

Previous ‘10-Q’:  ‘10-Q’ on 11/22/21 for 9/30/21   ·   Next:  ‘10-Q’ on 8/23/22 for 6/30/22   ·   Latest:  ‘10-Q’ on 11/20/23 for 9/30/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/23/22  Black Bird Biotech, Inc.          10-Q        3/31/22   52:2.6M                                   Discount Edgar/FA

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    358K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     20K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
10: R1          Cover                                               HTML     66K 
11: R2          Consolidated Balance Sheets                         HTML    108K 
12: R3          Consolidated Balance Sheets (Parenthetical)         HTML     36K 
13: R4          Consolidated Statements of Operations (Unaudited)   HTML    109K 
14: R5          Consolidated Statement of Changes in Stockholders'  HTML     47K 
                Equity (Deficit) (Unaudited)                                     
15: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     92K 
16: R7          Basis of Presentation and Nature of Operations      HTML     21K 
17: R8          Summary of Significant Accounting Policies and      HTML     29K 
                Going Concern                                                    
18: R9          Coronavirus Pandemic                                HTML     17K 
19: R10         Concentration of Credit Risk                        HTML     18K 
20: R11         Common Stock                                        HTML     25K 
21: R12         New Mitexstream Agreement                           HTML     25K 
22: R13         Asset Purchase Agreement                            HTML     18K 
23: R14         Intangible Asset                                    HTML     17K 
24: R15         Convertible Promissory Notes - Third Parties        HTML     37K 
25: R16         Stockholder Receivable                              HTML     17K 
26: R17         Amendments of Articles of Incorporation             HTML     18K 
27: R18         Related Party Transactions                          HTML     28K 
28: R19         Loans Payable - Related Parties                     HTML     22K 
29: R20         Subsequent Events                                   HTML     22K 
30: R21         Summary of Significant Accounting Policies and      HTML     47K 
                Going Concern (Policies)                                         
31: R22         New Mitexstream Agreement (Tables)                  HTML     23K 
32: R23         Convertible Promissory Notes - Third Parties        HTML     24K 
                (Tables)                                                         
33: R24         Related Party Transactions (Tables)                 HTML     23K 
34: R25         Summary of Significant Accounting Policies and      HTML     24K 
                Going Concern (Details Narrative)                                
35: R26         Concentration of Credit Risk (Details Narrative)    HTML     17K 
36: R27         Common Stock (Details Narrative)                    HTML     39K 
37: R28         New Mitexstream Agreement (Details)                 HTML     30K 
38: R29         Asset Purchase Agreement (Details Narrative)        HTML     28K 
39: R30         Intangible Asset (Details Narrative)                HTML     26K 
40: R31         Convertible Promissory Notes - Third Parties        HTML     27K 
                (Details)                                                        
41: R32         Convertible Promissory Notes - Third Parties        HTML    155K 
                (Details Narrative)                                              
42: R33         Stockholder Receivable (Details Narrative)          HTML     17K 
43: R34         Amendment of Articles of Incorporation (Details     HTML     20K 
                Narrative)                                                       
44: R35         Related Party Transactions (Details)                HTML     30K 
45: R36         Related Party Transactions (Details Narrative)      HTML     18K 
46: R37         Loans Payable Related Parties (Details Narrative)   HTML     18K 
47: R38         Subsequent Events (Details Narrative)               HTML     46K 
50: XML         IDEA XML File -- Filing Summary                      XML     87K 
48: XML         XBRL Instance -- bbbt_10q_htm                        XML    500K 
49: EXCEL       IDEA Workbook of Financial Reports                  XLSX     51K 
 7: EX-101.CAL  XBRL Calculations -- bbbt-20220331_cal               XML    110K 
 9: EX-101.DEF  XBRL Definitions -- bbbt-20220331_def                XML    257K 
 6: EX-101.LAB  XBRL Labels -- bbbt-20220331_lab                     XML    567K 
 8: EX-101.PRE  XBRL Presentations -- bbbt-20220331_pre              XML    444K 
 5: EX-101.SCH  XBRL Schema -- bbbt-20220331                         XSD    117K 
51: JSON        XBRL Instance as JSON Data -- MetaLinks              222±   282K 
52: ZIP         XBRL Zipped Folder -- 0001477932-22-003840-xbrl      Zip     90K

‘EX-101.CAL’   —   XBRL Calculations — bbbt-20220331_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="yes" encoding="windows-1252"?>
<!-- XBRL Document Created with XBRLMaster -->
<!-- Version: 2.3.08 -->
<!-- Based on XBRL 2.1 -->
<!-- Date of creation: 05/23/2022 -->
<!-- Software architectural design and coding: A'c Dharmapremananda Avt. -->
<!-- Copyright (c) 2022 I-NET Business Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://bbbt.com/role/Cover" xlink:href="bbbt-20220331.xsd#Cover" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConsolidatedBalanceSheets" xlink:href="bbbt-20220331.xsd#ConsolidatedBalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:href="bbbt-20220331.xsd#ConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConsolidatedStatementsOfOperationsUnaudited" xlink:href="bbbt-20220331.xsd#ConsolidatedStatementsOfOperationsUnaudited" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConsolidatedStatementOfChangesInStockholdersEquityDeficitUnaudited" xlink:href="bbbt-20220331.xsd#ConsolidatedStatementOfChangesInStockholdersEquityDeficitUnaudited" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:href="bbbt-20220331.xsd#ConsolidatedStatementsOfCashFlowsUnaudited" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/BasisOfPresentationAndNatureOfOperations" xlink:href="bbbt-20220331.xsd#BasisOfPresentationAndNatureOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/SummaryOfSignificantAccountingPoliciesAndGoingConcern" xlink:href="bbbt-20220331.xsd#SummaryOfSignificantAccountingPoliciesAndGoingConcern" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/CoronavirusPandemic" xlink:href="bbbt-20220331.xsd#CoronavirusPandemic" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConcentrationOfCreditRisk" xlink:href="bbbt-20220331.xsd#ConcentrationOfCreditRisk" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/CommonStock" xlink:href="bbbt-20220331.xsd#CommonStock" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/NewMitexstreamAgreement" xlink:href="bbbt-20220331.xsd#NewMitexstreamAgreement" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/AssetPurchaseAgreement" xlink:href="bbbt-20220331.xsd#AssetPurchaseAgreement" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/IntangibleAsset" xlink:href="bbbt-20220331.xsd#IntangibleAsset" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConvertiblePromissoryNotesThirdParties" xlink:href="bbbt-20220331.xsd#ConvertiblePromissoryNotesThirdParties" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/StockholderReceivable" xlink:href="bbbt-20220331.xsd#StockholderReceivable" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/AmendmentsOfArticlesOfIncorporation" xlink:href="bbbt-20220331.xsd#AmendmentsOfArticlesOfIncorporation" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/RelatedPartyTransactions" xlink:href="bbbt-20220331.xsd#RelatedPartyTransactions" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/LoansPayableRelatedParties" xlink:href="bbbt-20220331.xsd#LoansPayableRelatedParties" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/SubsequentEvents" xlink:href="bbbt-20220331.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/SummaryOfSignificantAccountingPoliciesAndGoingConcernPolicies" xlink:href="bbbt-20220331.xsd#SummaryOfSignificantAccountingPoliciesAndGoingConcernPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/NewMitexstreamAgreementTables" xlink:href="bbbt-20220331.xsd#NewMitexstreamAgreementTables" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConvertiblePromissoryNotesThirdPartiesTables" xlink:href="bbbt-20220331.xsd#ConvertiblePromissoryNotesThirdPartiesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/RelatedPartyTransactionsTables" xlink:href="bbbt-20220331.xsd#RelatedPartyTransactionsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/SummaryOfSignificantAccountingPoliciesAndGoingConcernDetailsNarrative" xlink:href="bbbt-20220331.xsd#SummaryOfSignificantAccountingPoliciesAndGoingConcernDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:href="bbbt-20220331.xsd#ConcentrationOfCreditRiskDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/CommonStockDetailsNarrative" xlink:href="bbbt-20220331.xsd#CommonStockDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/NewMitexstreamAgreementDetails" xlink:href="bbbt-20220331.xsd#NewMitexstreamAgreementDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/AssetPurchaseAgreementDetailsNarrative" xlink:href="bbbt-20220331.xsd#AssetPurchaseAgreementDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/IntangibleAssetDetailsNarrative" xlink:href="bbbt-20220331.xsd#IntangibleAssetDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConvertiblePromissoryNotesThirdPartiesDetails" xlink:href="bbbt-20220331.xsd#ConvertiblePromissoryNotesThirdPartiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/ConvertiblePromissoryNotesThirdPartiesDetailsNarrative" xlink:href="bbbt-20220331.xsd#ConvertiblePromissoryNotesThirdPartiesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/StockholderReceivableDetailsNarrative" xlink:href="bbbt-20220331.xsd#StockholderReceivableDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/AmendmentOfArticlesOfIncorporationDetailsNarrative" xlink:href="bbbt-20220331.xsd#AmendmentOfArticlesOfIncorporationDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/RelatedPartyTransactionsDetails" xlink:href="bbbt-20220331.xsd#RelatedPartyTransactionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:href="bbbt-20220331.xsd#RelatedPartyTransactionsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:href="bbbt-20220331.xsd#LoansPayableRelatedPartiesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://bbbt.com/role/SubsequentEventsDetailsNarrative" xlink:href="bbbt-20220331.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConsolidatedBalanceSheets" xlink:title="000002 - Statement - Consolidated Balance Sheets">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="loc_us-gaapPrepaidExpenseCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssets" xlink:label="loc_us-gaapOtherAssets"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsNet"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesGross" xlink:label="loc_us-gaapFurnitureAndFixturesGross"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapFurnitureAndFixturesGross" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositAssets" xlink:label="loc_us-gaapDepositAssets"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherAssets" xlink:to="loc_us-gaapDepositAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssets" xlink:type="arc" weight="1"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesPayableCurrent" xlink:label="loc_us-gaapNotesPayableCurrent"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapNotesPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesCurrent" xlink:label="loc_us-gaapDueToRelatedPartiesCurrent"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDueToRelatedPartiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesSubscriptions" xlink:label="loc_us-gaapCommonStockSharesSubscriptions"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockSharesSubscriptions" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
<link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:title="000003 - Statement - Consolidated Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConsolidatedStatementsOfOperationsUnaudited" xlink:title="000004 - Statement - Consolidated Statements of Operations (unaudited)">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues" xlink:label="loc_us-gaapRevenues"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapRevenues" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseAndRentalExpense" xlink:label="loc_us-gaapLeaseAndRentalExpense"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLeaseAndRentalExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCollateralFee" xlink:label="loc_us-gaapDebtInstrumentCollateralFee"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDebtInstrumentCollateralFee" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketingAndAdvertisingExpense" xlink:label="loc_us-gaapMarketingAndAdvertisingExpense"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapMarketingAndAdvertisingExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalFees" xlink:label="loc_us-gaapLegalFees"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapLegalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="bbbt-20220331.xsd#bbbt_AmortizationExpense" xlink:label="loc_bbbtAmortizationExpense"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_bbbtAmortizationExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherExpenses" xlink:label="loc_us-gaapOtherExpenses"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapOtherExpenses" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfessionalFees" xlink:label="loc_us-gaapProfessionalFees"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapProfessionalFees" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConsolidatedStatementOfChangesInStockholdersEquityDeficitUnaudited" xlink:title="000005 - Statement - Consolidated Statement of Changes in Stockholders' Equity (Deficit) (unaudited)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" xlink:title="000006 - Statement - Consolidated Statements of Cash Flows (unaudited)">
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilities"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInterestPayableNet" xlink:label="loc_us-gaapIncreaseDecreaseInInterestPayableNet"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInterestPayableNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="bbbt-20220331.xsd#bbbt_PrepaidConsultingFees" xlink:label="loc_bbbtPrepaidConsultingFees"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_bbbtPrepaidConsultingFees" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="bbbt-20220331.xsd#bbbt_DebtAmortization" xlink:label="loc_bbbtDebtAmortization"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_bbbtDebtAmortization" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="bbbt-20220331.xsd#bbbt_StockIssuedForServices" xlink:label="loc_bbbtStockIssuedForServices"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_bbbtStockIssuedForServices" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="bbbt-20220331.xsd#bbbt_PurchaseOfFurnitureAndEquipment" xlink:label="loc_bbbtPurchaseOfFurnitureAndEquipment"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_bbbtPurchaseOfFurnitureAndEquipment" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForPurchaseOfOtherAssets1" xlink:label="loc_us-gaapPaymentsForPurchaseOfOtherAssets1"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsForPurchaseOfOtherAssets1" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromShortTermDebt" xlink:label="loc_us-gaapProceedsFromShortTermDebt"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromShortTermDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfRelatedPartyDebt" xlink:label="loc_us-gaapRepaymentsOfRelatedPartyDebt"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfRelatedPartyDebt" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="bbbt-20220331.xsd#bbbt_FinancingFeesPaid" xlink:label="loc_bbbtFinancingFeesPaid"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_bbbtFinancingFeesPaid" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/BasisOfPresentationAndNatureOfOperations" xlink:title="000007 - Disclosure - BASIS OF PRESENTATION AND NATURE OF OPERATIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/SummaryOfSignificantAccountingPoliciesAndGoingConcern" xlink:title="000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/CoronavirusPandemic" xlink:title="000009 - Disclosure - CORONAVIRUS PANDEMIC"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConcentrationOfCreditRisk" xlink:title="000010 - Disclosure - CONCENTRATION OF CREDIT RISK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/CommonStock" xlink:title="000011 - Disclosure - COMMON STOCK"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/NewMitexstreamAgreement" xlink:title="000012 - Disclosure - NEW MITEXSTREAM AGREEMENT"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/AssetPurchaseAgreement" xlink:title="000013 - Disclosure - ASSET PURCHASE AGREEMENT"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/IntangibleAsset" xlink:title="000014 - Disclosure - INTANGIBLE ASSET"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConvertiblePromissoryNotesThirdParties" xlink:title="000015 - Disclosure - CONVERTIBLE PROMISSORY NOTES - THIRD PARTIES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/StockholderReceivable" xlink:title="000016 - Disclosure - STOCKHOLDER RECEIVABLE"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/AmendmentsOfArticlesOfIncorporation" xlink:title="000017 - Disclosure - AMENDMENTS OF ARTICLES OF INCORPORATION"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/RelatedPartyTransactions" xlink:title="000018 - Disclosure - RELATED PARTY TRANSACTIONS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/LoansPayableRelatedParties" xlink:title="000019 - Disclosure - LOANS PAYABLE - RELATED PARTIES"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/SubsequentEvents" xlink:title="000020 - Disclosure - SUBSEQUENT EVENTS"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/SummaryOfSignificantAccountingPoliciesAndGoingConcernPolicies" xlink:title="000021 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/NewMitexstreamAgreementTables" xlink:title="000022 - Disclosure - NEW MITEXSTREAM AGREEMENT (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConvertiblePromissoryNotesThirdPartiesTables" xlink:title="000023 - Disclosure - CONVERTIBLE PROMISSORY NOTES - THIRD PARTIES (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/RelatedPartyTransactionsTables" xlink:title="000024 - Disclosure - RELATED PARTY TRANSACTIONS (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/SummaryOfSignificantAccountingPoliciesAndGoingConcernDetailsNarrative" xlink:title="000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND GOING CONCERN (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConcentrationOfCreditRiskDetailsNarrative" xlink:title="000026 - Disclosure - CONCENTRATION OF CREDIT RISK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/CommonStockDetailsNarrative" xlink:title="000027 - Disclosure - COMMON STOCK (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/NewMitexstreamAgreementDetails" xlink:title="000028 - Disclosure - NEW MITEXSTREAM AGREEMENT (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/AssetPurchaseAgreementDetailsNarrative" xlink:title="000029 - Disclosure - ASSET PURCHASE AGREEMENT (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/IntangibleAssetDetailsNarrative" xlink:title="000030 - Disclosure - INTANGIBLE ASSET (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConvertiblePromissoryNotesThirdPartiesDetails" xlink:title="000031 - Disclosure - CONVERTIBLE PROMISSORY NOTES - THIRD PARTIES (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/ConvertiblePromissoryNotesThirdPartiesDetailsNarrative" xlink:title="000032 - Disclosure - CONVERTIBLE PROMISSORY NOTES - THIRD PARTIES (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/StockholderReceivableDetailsNarrative" xlink:title="000033 - Disclosure - STOCKHOLDER RECEIVABLE (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/AmendmentOfArticlesOfIncorporationDetailsNarrative" xlink:title="000034 - Disclosure - AMENDMENT OF ARTICLES OF INCORPORATION (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/RelatedPartyTransactionsDetails" xlink:title="000035 - Disclosure - RELATED PARTY TRANSACTIONS (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/RelatedPartyTransactionsDetailsNarrative" xlink:title="000036 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/LoansPayableRelatedPartiesDetailsNarrative" xlink:title="000037 - Disclosure - LOANS PAYABLE RELATED PARTIES (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://bbbt.com/role/SubsequentEventsDetailsNarrative" xlink:title="000038 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)"/>
</link:linkbase>

↑Top
Filing Submission 0001477932-22-003840   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Fri., May 17, 9:24:29.1pm ET